Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cytokinetics
(NQ:
CYTK
)
56.50
-0.56 (-0.98%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cytokinetics
< Previous
1
2
3
4
5
6
7
Next >
CYTK Stock Earnings: Cytokinetics Misses EPS, Misses Revenue for Q2 2024
August 08, 2024
CYTK stock results show that Cytokinetics missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Cytokinetics' Wild Ride: Can Investors Forgive The Royalty Pharma Deal?
July 11, 2024
CEO Robert Blum says there are key components to the funding arrangement with Royalty Pharma that investors are missing.
Via
Investor's Business Daily
7 Biotech Stocks to Boost Your Portfolio to Peak Health
June 26, 2024
With biotech stocks commanding a permanently relevant narrative, you can’t afford to ignore these highly endorsed ideas.
Via
InvestorPlace
Peering Into Cytokinetics's Recent Short Interest
June 07, 2024
Via
Benzinga
June’s Biotech Boom: 3 Stocks to Buy for a Summertime Surge
June 05, 2024
Biotech surge alert! Discover three biotech stocks to buy as they catch up with the market in the rest of 2024.
Via
InvestorPlace
Dow Dips Over 550 Points; BJ's Wholesale Club Earnings Beat Views
May 23, 2024
Via
Benzinga
Topics
Earnings
Stocks
Exposures
Financial
US Equities
(CYTK) - Analyzing Cytokinetics's Short Interest
May 01, 2024
Via
Benzinga
$100 Invested In Cytokinetics 5 Years Ago Would Be Worth This Much Today
April 03, 2024
Via
Benzinga
Heart Disease-Focused Cytokinetics Operations Are On Track Despite Acquisition Uncertainty, Analysts Observe
May 23, 2024
Unlock the latest on Royalty Pharma plc & Cytokinetics Inc.'s strategic funding collaboration for aficamten's commercialization and cardiovascular pipeline expansion.
Via
Benzinga
8 Health Care Stocks Whale Activity In Today's Session
May 23, 2024
Via
Benzinga
Stocks Mixed Amid Flood Of Economic Data
May 23, 2024
The Nasdaq is up triple digits midday, trading at fresh record highs thanks to Nvidia's post-earnings pop.
Via
Talk Markets
12 Health Care Stocks Moving In Thursday's Intraday Session
May 23, 2024
Via
Benzinga
Gold Falls Sharply; US Composite PMI Surges In May
May 23, 2024
Via
Benzinga
2 Incredible Growth Stocks to Buy Right Now
March 20, 2024
These two biotech stocks could be big winners in the years ahead.
Via
The Motley Fool
Here's How Much $100 Invested In Cytokinetics 10 Years Ago Would Be Worth Today
March 15, 2024
Via
Benzinga
Why Cytokinetics (CYTK) Shares Are Falling
May 23, 2024
Cytokinetics shares are trading lower by 15.8% during Thursday's session. The company announced the pricing of a public offering of 9,803,922 shares.
Via
Benzinga
Why NVIDIA Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
May 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 23, 2024
Via
Benzinga
NVIDIA To Rally Over 39%? Here Are 10 Top Analyst Forecasts For Thursday
May 23, 2024
Via
Benzinga
VF Corp Posts Weak Q4 Results, Joins NetEase, Cytokinetics And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
May 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
May 22, 2024
Via
Benzinga
Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline
May 22, 2024
From
Royalty Pharma plc; Cytokinetics
Via
GlobeNewswire
10 Health Care Stocks Whale Activity In Today's Session
May 17, 2024
Via
Benzinga
Cytokinetics Reveals More From The Study That Boosted Shares 83% In A Day
May 13, 2024
The company is hoping to take on Bristol Myers Squibb's Camzyos, a treatment for obstructive HCM.
Via
Investor's Business Daily
CYTK Stock Earnings: Cytokinetics Misses EPS, Misses Revenue for Q1 2024
May 08, 2024
CYTK stock results show that Cytokinetics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
May 07, 2024
Investors concerned about broader market undulations may want to consider the resilience narrative of these biotech stocks to buy.
Via
InvestorPlace
3 Biotech Stocks to Buy on the Dip: April 2024
April 26, 2024
With medical innovation being a resilient space, investors can have confidence with these biotech stocks to buy on the dip.
Via
InvestorPlace
7 Biotech Stocks Ready to Ride the Sector’s Resurgence
March 18, 2024
With investors seeking new opportunities with certain segments appearing stretched, biotech stocks offer a viable canvas.
Via
InvestorPlace
Masters In Trading - Saturday, March 16
March 16, 2024
In this snippet from Friday's trading session, I review my various trades from the past week.
Via
Talk Markets
7 Biotech Stocks to Buy as Sector Rotation Ramps Up
March 13, 2024
With digital innovation possibly getting overextended, now’s the time to consider biotech stocks for an incoming rotation.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.